Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

Ole Jannik Bjerrum, Sascha Eichendorff, Nada Bassam Alkis

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalTherapeutic Innovation & Regulatory Science
Number of pages6
ISSN2168-4790
DOIs
Publication statusPublished - 2019

Cite this